PW
SRPT icon

Pandora Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Pandora Wealth’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.1K Hold
700
– – 0.01% 178
2025
Q3 		$13.5K Hold
700
– – 0.01% 182
2025
Q2 		$12K Hold
700
– – 0.01% 190
2025
Q1 		$44.7K Buy
+700
New +$73.7K 0.03% 148

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Pandora Wealth's SRPT Position: Q4 2025 in Review

Pandora Wealth held its Sarepta Therapeutics (SRPT) position steady in Q4 2025 at 700 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #178.

Pandora Wealth first reported a position in SRPT in Q1 2025 and has held it in 4 quarters since. The position peaked at $44.7K in Q1 2025. 346 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Pandora Wealth held 700 shares of Sarepta Therapeutics worth $15.1K as of Q4 2025.
  • Pandora Wealth left its Sarepta Therapeutics share count unchanged in Q4 2025.
  • Sarepta Therapeutics made up 0.01% of Pandora Wealth's portfolio in Q4 2025, its #178 holding.
  • Pandora Wealth first reported a position in Sarepta Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Pandora Wealth's Sarepta Therapeutics position peaked at $44.7K in Q1 2025.
  • 346 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.